I 
117TH CONGRESS 
1ST SESSION H. R. 5086 
To amend the Comprehensive Addiction and Recovery Act of 2016 to author-
ize the Attorney General, in coordination with the Administrator of 
the Drug Enforcement Administration, the Secretary of Health and 
Human Services, and the Director of the Office of National Drug Control 
Policy, to award grants to covered entities to establish or maintain 
disposal sites for unwanted prescription medications, and for other pur-
poses. 
IN THE HOUSE OF REPRESENTATIVES 
AUGUST 24, 2021 
Ms. BONAMICI (for herself, Mr. MOONEY, Ms. KUSTER, Mr. FITZPATRICK, 
and Ms. WILD) introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To amend the Comprehensive Addiction and Recovery Act 
of 2016 to authorize the Attorney General, in coordina-
tion with the Administrator of the Drug Enforcement 
Administration, the Secretary of Health and Human 
Services, and the Director of the Office of National Drug 
Control Policy, to award grants to covered entities to 
establish or maintain disposal sites for unwanted pre-
scription medications, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
02:07 Aug 25, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5086.IH
H5086
kjohnson on DSK79L0C42PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Safe Disposal of 
Opioids Act of 2021’’. 
SEC. 2. GRANTS FOR DISPOSAL SITES FOR UNWANTED PRE-
SCRIPTION MEDICATIONS. 
Section 203 of the Comprehensive Addiction and Re-
covery Act of 2016 (21 U.S.C. 822a) is amended by add-
ing at the end the following: 
‘‘(c) GRANTS FOR DISPOSAL SITES FOR UNWANTED 
PRESCRIPTION MEDICATIONS.— 
‘‘(1) GRANTS.— 
‘‘(A) AWARDS.—In carrying out subsection 
(b), the Attorney General shall award grants to 
covered entities to establish or maintain dis-
posal sites for unwanted prescription medica-
tions. 
‘‘(B) LIMITATION.—Of the total amount of 
awards under subparagraph (A) for a fiscal 
year, the Attorney General shall not award 
more than 10 percent to covered entities that 
are— 
‘‘(i) State, local, or tribal law enforce-
ment agencies; or 
‘‘(ii) manufacturers, distributors, or 
reverse distributors of prescription medica-
tions. 
VerDate Sep 11 2014 
02:07 Aug 25, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5086.IH
H5086
kjohnson on DSK79L0C42PROD with BILLS
‘‘(2) DISCOUNTS FOR ELIGIBLE PATIENTS.— 
‘‘(A) IN
GENERAL.—The Secretary of 
Health and Human Services shall establish a 
mechanism by which amounts paid by an eligi-
ble patient for an active opioid are discounted 
at time of payment or purchase to ensure that 
such patient does not pay any amount attrib-
utable to a fee under paragraph (3), with as lit-
tle burden on the patient as possible. 
‘‘(B) DEFINITION.—For purposes of sub-
paragraph (A), the term ‘eligible patient’ 
means— 
‘‘(i) a patient for whom any active 
opioid (as so defined) is prescribed to treat 
pain relating to cancer or cancer treat-
ment; 
‘‘(ii) a patient participating in hospice 
care; and 
‘‘(iii) in the case of the death or inca-
pacity of a patient described in subpara-
graph (A) or (B) or any similar situation 
as determined by the Secretary of Health 
and Human Services, the appropriate fam-
ily member, medical proxy, or similar rep-
resentative or the estate of such patient. 
VerDate Sep 11 2014 
02:07 Aug 25, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5086.IH
H5086
kjohnson on DSK79L0C42PROD with BILLS
‘‘(3) FEES.— 
‘‘(A) IN GENERAL.—There is hereby im-
posed on the sale of any active opioid by the 
manufacturer, producer, or importer a fee equal 
to 1 cent per 100 milligrams so sold. 
‘‘(B) SPECIAL RULES.— 
‘‘(i) DEFINITION.—In this paragraph, 
the term ‘active opioid’— 
‘‘(I) means any controlled sub-
stance (as defined in section 102 of 
the Controlled Substances Act, as in 
effect on the date of the Safe Disposal 
of Opioids Act of 2021) which is 
opium, an opiate, or any derivative 
thereof; and 
‘‘(II) excludes any prescribed 
drug which is used exclusively for the 
treatment of opioid addiction as part 
of a medically assisted treatment ef-
fort. 
‘‘(ii) EXCLUSION OF OTHER INGREDI-
ENTS.—In the case of a product that in-
cludes an active opioid and another ingre-
dient, subparagraph (A) shall apply only to 
VerDate Sep 11 2014 
02:07 Aug 25, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5086.IH
H5086
kjohnson on DSK79L0C42PROD with BILLS
the portion of such product that is an ac-
tive opioid. 
‘‘(4) AUTHORIZATION
OF
APPROPRIATIONS.— 
For fiscal year 2022 and each subsequent fiscal 
year, there is authorized to be appropriated to carry 
out this subsection an amount not to exceed the ag-
gregate amount of the fees collected pursuant to 
paragraph (3).’’. 
Æ 
VerDate Sep 11 2014 
02:07 Aug 25, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H5086.IH
H5086
kjohnson on DSK79L0C42PROD with BILLS